Results of concomitant cryoablation for atrial fibrillation during mitral valve surgery.

ABSTRACT:

Objectives

Concomitant atrial fibrillation ablation during mitral valve (MV) surgery using radio frequency energy sources has been reported previously with excellent outcomes. However, data regarding the effectiveness of concomitant cryoablation remain limited. This study aimed to assess the efficacy of concomitant cryoablation in patients scheduled for MV surgery.

Methods

Between 2012 and 2020, 242 adult patients who underwent MV surgery and concomitant cryoablation were included. Data on rhythm, medication status and clinical events were assessed at 3, 6 and 12 months, then annually thereafter.

Results

Early mortality was 0.4%. The mean follow-up period duration was 43.9 months. The survival rates at 1, 3 and 5 years were 97.3%, 94.3% and 87.7%, respectively. The ra

SUBMITTER: Bogachev-Prokophiev A 

PROVIDER: S-EPMC8972332 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature